Researchers make breakthrough discovery in cancer treatment – NASAL OXYGEN
Researchers make breakthrough discovery in cancer treatment – NASAL OXYGEN
Northeastern researchers make breakthrough discovery in cancer treatment – NASAL OXYGEN
Northeastern University researchers have found that inhaling supplemental oxygen—40 to 60 percent oxygen as opposed to the 21 percent oxygen in air—can weaken immunosuppression and awaken anti-tumor cells. The new approach, some 30 years in the making, could dramatically increase the survival rate of patients with cancer, which kills some 8 million people each year. The breakthrough findings were published Wednesday in Science Translational Medicine.
Michail Sitkovsky, an immunophysiology researcher at Northeastern University, and his team found that supplemental oxygenation inhibits the hypoxia-driven accumulation of adenosine in the tumor microenvironment and weakens immunosuppression. This, in turn, could improve cancer immunotherapy and shrink tumors by unleashing anti-tumor T lymphocytes and natural killer cells.
“Breathing supplemental oxygen opens up the gates of the tumor fortress and wakes up ‘sleepy’ anti-tumor cells, enabling these soldiers to enter the fortress and destroy it,” explained Sitkovsky, the Eleanor W. Black Chair and Professor of Immunophysiology and Pharmaceutical Biotechnology at Northeastern and the founding director of the university’s New England Inflammation and Tissue Protection Institute.
Genes Respond to Restoration of Oxygen Signaling
Majid Ali, M.D.
A cancer cell is a fermentative cell – that is a cell whose metabolic process converts sugar to acids, gases, and/or alcohol – that is oxygen suffocating materials.
This is the core of my Oxygen Model of Cancer. However this central metabolic characteristic feature of cancer cell is not irreversible, as is commonly believed. Control of cellular fermentation is the central goal of my Oxygen Protocol for Cancer for treating cancer.
I have illustrated the clinical significance of these models in a series of articles and my two books entitled “Oxygen Model of Cancer” and “Oxygen Protocol for Cancer.” In previous publications, I presented case histories of patients whose control of cancer over long periods without surgery, radiotherapy, and chemotherapy challenges the validity of the Warburg Effect.
The matter of the Warbug Effect (see below) is crucial in all deliberations of oxygen issues in the treatment of cancer. Doctors who do not study molecular biology of oxygen and oxygen signaling continue to make silly statements about the central roles of oxygen in the cause and treatment of cancer. Before addressing this subject, below are brief outlines of my models of cancer.
My Oxygen Model of Cancer
My Oxygen Model of Cancer is an extension of my Oxygen Model of Health and Disease. It is a unifying model that explains all aspects of malignant tumors—causes, clinical course, consequences, and control—on the basis of disturbed oxygen function. The most important among these are:
(1) impaired or blocked oxygen signaling;
(2) interrupted oxygen’s ATP energy generation;
(3) diminished oxygen’s detergent functions;
(4) interrupted oxygen’s cellular detox functions;
(5) impeded oxygen-governed cellular repair mechanisms; and
(6) oxygen-regulated cell membrane and matrix functions. These abnormalities usually begin in early life but may develop at any time during life.
The Oxygen Protocol for Cancer
In controlling and eradicating cancer, the Oxygen Model requires that all relevant “oxygen issues” in a case—whether or not related to the recognizable aspects of cancerous tumors—must be effectively addressed. In my experience, the clinical results for individuals with cancer are far superior when all relevant nutritional, environmental, and stress-related threats to oxygen signaling are effectively addressed. Specifically, these issues include fermentation, increased gut permeability (leaky gut state), and glucose-insulin-roller coasters.
The Warbug Effect
In 1923, the German biochemist Otto Warburg published evidence for a respiratory-to-fermentative shift in energy generation (glycolysis) in cancer cells. Specifically, he documented the presence of pyruvate-to-lactate conversion, which is the biochemical hallmark of metabolism under conditions of lack of oxygen. Warburg claimed that glycolysis predominates in tumor cells even when oxygen is plentiful. This is referred to as the ‘Warburg effect’ or aerobic glycolysis. To my knowledge, Warburg never mentioned oxygen signaling in his writings, even in later years after he had received two unshared Nobel Prizes. That is understandable since the many influences of oxygen on proteins, such as hypoxia-inducible factors, had not been discovered during his lifetime.
Dysoxygenosis and Deranged Oxygen Signaling
In 1998, I introduced the term dysoxygenosis for impaired oxygen functions, which includes abnormal oxygen signaling. I devote large sections of my two-volume book on cancer to these subjects. The core aspects of these dysfunctions are included above.
The Warburg Effect Is Reversible
In previous publications, I have asserted that the Warburg Effect is not irreversible, as Warburg originally claimed. Regrettably, the irreversibility of the Effect still is believed widely, in spite of mounting evidence against it, by those who think ethe behavior of genes controlling cancer metabolism cannot be altered.
